China's medical products administrator granted MGI Tech (SHA:688114) subsidiary Qingdao MGI Intelligent Manufacturing Technology medical device approval for its gene sequencer, according to a Tuesday filing with the Shanghai Stock Exchange.
The gene sequencer is used in human DNA samples to help with the diagnosis of diseases, the filing said.
Shares rose 2% during Tuesday's late morning trading.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。